Starling Oncology, Inc. (STLN) income statement
STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
$3.00−0.18 (-5.66%)
Close on Nov 20, 2026Market cap $305.75MP/E –Yield –
Starling Oncology, Inc. financial ratios
See a number that looks wrong?